Combination Approaches in Photodynamic Therapies for Cancer
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (20 May 2024) | Viewed by 13099
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cancer has always been a concern among people and a challenge for scientists and researchers around the world. This is due to its treatment resistance and recurrence. With increasing cases of cancer each year, it has become important to focus on emerging techniques for effective cancer therapy. Photodynamic therapy is one such advanced approach that is gaining interest worldwide due to its post-treatment results and less invasive nature. However, to improve results further and to increase life expectancy among patients, other fields of research are focusing on combination therapies with light. The use of nanoparticles, plant compounds, certain metal complexes, and antibodies in laser therapy has increased the treatment efficacy of cancer cells while causing minimal side effects in normal cells. This special issue is designed to motivate researchers to share their opinions, novel concepts, reviews, and research articles on cancer therapy using photodynamic therapy along with other advanced combination approaches from nanotechnology, phytomedicine and chemistry.
Dr. Rahul Chandran
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- photodynamic therapy
- photosensitizers
- cancer
- reactive oxygen species
- cancer stem cells
- nanoparticles
- metal complexes
- nanoconjugates
- tumor microenvironment
- phytotherapy
- plant compounds
- immune targeting
- drug resistance
- spheroids
- combination therapy
- apoptosis
- cell death markers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.